Can Johnson & Johnson Get Its Mojo Back?

The stock market has gone through a correction to begin 2018, and healthcare giant Johnson & Johnson (NYSE:JNJ) has been particularly susceptible to the market's declines. A 7% decline so far this year isn't a huge downward move, but it still flies in the face of beliefs among many investors that the company's solid performance in 2017 reflected its stability in the face of market uncertainty.